Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) Director Julie Mchugh sold 22,766 shares of Ironwood Pharmaceuticals stock in a transaction dated Monday, June 10th. The shares were sold at an average price of $6.29, for a total transaction of $143,198.14. Following the transaction, the director now owns 139,528 shares of the company’s stock, valued […]
Redwood Investment Management LLC lessened its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 14.3% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 282,619 shares of the biotechnology company’s stock after selling 47,188 shares during the period. Redwood Investment […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has earned a consensus rating of “Buy” from the five research firms that are covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have issued ratings on the stock in […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has been assigned a consensus rating of “Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy rating. The average 1 year target price among brokerages that have updated their coverage on the […]
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) shares traded up 5.5% during trading on Wednesday . The stock traded as high as $8.19 and last traded at $8.18. 351,520 shares were traded during mid-day trading, a decline of 92% from the average session volume of 4,272,103 shares. The stock had previously closed at $7.75. […]